Danazol Suppresses Both Spontaneous and Activated Human Lymphocyte‐Mediated Cytotoxicity

article OA: closed CC0 ⤵ 7 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

Danazol suppressed spontaneous and IL-2/IFN-alpha-activated human lymphocyte-mediated cytotoxicity, with activated cytotoxicity inhibition persisting after drug removal.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Danazol is an effective drug in the treatment of endometriosis. Previous reports suggest that it can act by influencing the immune system. Thus, in this study we evaluated whether danazol is able to affect the expression of natural and activated cytotoxicity by human peripheral blood lymphocytes (PBL). A cytotoxicity assay by 51Cr release was performed to determine the effect of danazol on lymphocyte cytotoxic response toward an erythroleukemic cell line (K562). A significant suppression of spontaneous cytotoxicity was observed when lymphocytes were pretreated for 18 h with danazol at the concentration of 5 x 10(-6) M. In addition, danazol could significantly inhibit both IL-2- and INF alpha-activated cytotoxicity at the concentration of 10(-5) M. Following 18 h exposure to danazol, PBL were able to completely recover their spontaneous but not activated cytotoxic potential upon further in vitro incubation (18 h) in absence of the drug. The biological significance of danazol as an inhibitor of immune function under experimentally defined conditions is discussed in relation to its possible role in vivo.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Cytotoxicity, Immunologic Danazol Immunosuppressive Agents Killer Cells, Lymphokine-Activated Killer Cells, Natural Cytotoxicity, Immunologic Danazol Depression, Chemical Humans Immunosuppressive Agents Interferon-alpha Interferon-alpha Interleukin-2 Interleukin-2 Killer Cells, Lymphokine-Activated Killer Cells, Lymphokine-Activated Killer Cells, Natural Killer Cells, Natural Lymphocyte Activation Lymphocyte Activation

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (32)

Cited by (7)

Source provenance

europepmc
last seen: 2026-08-17T06:11:01.428247+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:44.647872+00:00
License: CC0 · commercial use OK